Overall PRDX1 median levels were significantly higher in stroke patients than in the control population: 6.9 ± 13.7 vs. 3.5 ± 4.5 ng/mL (p < 0.01) (Fig. 1, Table 2). This evidence concerns the gene PRDX1 and Stroke.